Sirnaomics announced a research report on the new mechanism of action of the RNAi anti-cancer therapy drug STP707 for the treatment of solid tumors. . .
This research was published in "Nucleic Acid Research Cancer", a cutting-edge peer-reviewed journal in the field of nucleic acid therapy....